Expertise in
3
conditions

Jesus Troya

Madrid, MD, ES 
Expertise in
3
conditions
Madrid, MD, ES 
OverviewLocationsClinical Research

Overview

Jesus Troya practices in Madrid, Spain. Mr. Troya is highly rated in 3 conditions, according to our data. His top areas of expertise are HIV/AIDS, Cerebral Hypoxia, Hepatitis C, and COVID-19.

His clinical research consists of co-authoring 66 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Madrid, MD, Spain
Other Locations
Valencia, VC, Spain
Vallecas, MD, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Bicentric, Phase 2, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Maraviroc Associated With Standard Treatment in Hospitalized Patients With Pulmonary SARS-CoV-2 Infection (COVID-19).
Bicentric, Phase 2, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Maraviroc Associated With Standard Treatment in Hospitalized Patients With Pulmonary SARS-CoV-2 Infection (COVID-19).
Enrollment Status: Terminated
Publish Date: March 11, 2022
Intervention Type: Other, Drug
Study Drug: Maraviroc
Study Phase: Phase 2
Multicenter Retrospective Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice
Multicenter Retrospective Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice
Enrollment Status: Completed
Publish Date: February 05, 2020
View 1 Less Clinical Trial

66 Total Publications

Long-acting cabotegravir and rilpivirine for the treatment of people with HIV: current landscape and challenges ahead.
Long-acting cabotegravir and rilpivirine for the treatment of people with HIV: current landscape and challenges ahead.
Journal: The Journal of antimicrobial chemotherapy
Published: August 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Troya's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile